NCT03442686

Brief Summary

The Compass Course is an 8-session progressive structure that was developed based on theoretical and scientific evidence from psychology and occupational therapy. The goal of the intervention is to provide participants with information, tools, and support that help them move towards reclaiming a sense of self-grounded purpose in daily life. The study will use a convenience sample of breast cancer survivors to evaluate the efficacy of the Compass Course intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
41

participants targeted

Target at P25-P50 for not_applicable breast-cancer

Timeline
Completed

Started Mar 2018

Typical duration for not_applicable breast-cancer

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 16, 2018

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 22, 2018

Completed
8 days until next milestone

Study Start

First participant enrolled

March 2, 2018

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2021

Completed
Last Updated

May 12, 2021

Status Verified

May 1, 2021

Enrollment Period

3.2 years

First QC Date

February 16, 2018

Last Update Submit

May 10, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in psychological well-being

    Using the Psychological Scales of Wellbeing questionnaire (Ryff, 1989; Ryff, \& Keyes, 1995), psychological wellbeing pre- and post- intervention will be tracked.

    Will be administered at Week 0 (pre-testing), at Week 12 (session 8), and at 3 month follow up

Secondary Outcomes (10)

  • Recruitment

    Up to 1 month after IRB approval

  • Time of pre-testing session

    Duration of pre-testing session (approximately 2 hours) at week 0 to week 1

  • Time of testing session

    Each week from week 2 through week 8, approximately 2 hours at each session

  • Time of post-testing session

    Duration of session 8 (at week 12), approximately 1 hour

  • Homework completion

    Each week from week 2 through week 8

  • +5 more secondary outcomes

Study Arms (2)

Spring 2018 Compass Course Group

EXPERIMENTAL

Two groups of up to 15 participants (30 total) will receive the study intervention during Spring 2018. All participants will complete study questionnaires before and after the Spring sessions.

Behavioral: Compass Course

Spring 2018 Comparison Group

NO INTERVENTION

Two groups of up to 15 participants will receive the study intervention in Fall 2018. All participants will complete study questionnaires before and after the Spring sessions. Those who enroll in the study and agree to participate in the Fall sessions will serve as a no-treatment comparison group.

Interventions

Compass CourseBEHAVIORAL

An 8-session group intervention that integrates education, support, self-reflection, and action-expectation to help people reaffirm or reconstruct self-grounded purpose after significant life events/transitions. The 8 sessions extend over 2-3 months, with 7 weekly sessions and the final session 1 month after Session 7. The intervention, called the Compass Course is structured around the 6 dimensions of flourishing (autonomy, self-acceptance, personal growth, relationships, purpose in life, external mastery), the goal of which is to help people enact behaviors that move them forward in reframing a sense of self and reaffirming or reconstructing a sense of purpose in their daily lives.

Spring 2018 Compass Course Group

Eligibility Criteria

Age25 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age or older
  • Completed treatment (such as chemotherapy, radiation, surgery) for Stage 0, 1, 2, or 3 breast cancer at least 2 months prior to participating in the Compass Course intervention
  • English speaking
  • High school diploma or GED
  • Able to see, hear, speak (with or without assistive devices)
  • Able to provide own transportation to sessions
  • Willing and able to commit to attend all 8 intervention sessions

You may not qualify if:

  • Stage 4 breast cancer or any other stage 4 cancer
  • Actively receiving chemotherapy or radiation treatments for cancer. (However, patients may be on Herceptin and/or endocrine treatment and participate in the study.)
  • History of neurologic disorder (such as stroke or brain injury) with residual impairments that likely interfere with learning
  • Any medical condition (physical or mental health) that interferes with the performance of everyday activities and roles.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Courage Kenny Rehabilitation Institute

Golden Valley, Minnesota, 55422, United States

Location

Abbott Northwestern Hospital

Minneapolis, Minnesota, 55407, United States

Location

Allina Health Shoreview Clinic

Shoreview, Minnesota, 55126, United States

Location

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Mary Radomski, PhD, OTR/L

    Allina Health

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
CROSSOVER
Model Details: This study uses a wait list control design. One group of participants will be evaluated before receiving the intervention (in Spring 2018) and compared to those who receive the intervention in Spring 2018. The first group will go on to receive the intervention in Fall 2018.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Scientific Advisor

Study Record Dates

First Submitted

February 16, 2018

First Posted

February 22, 2018

Study Start

March 2, 2018

Primary Completion

May 1, 2021

Study Completion

May 1, 2021

Last Updated

May 12, 2021

Record last verified: 2021-05

Locations